Modeling poliovirus transmission and responses in New York State.

New York immunization modeling outbreak polio

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
19 Aug 2023
Historique:
received: 24 05 2023
revised: 08 08 2023
accepted: 16 08 2023
medline: 19 8 2023
pubmed: 19 8 2023
entrez: 19 8 2023
Statut: aheadofprint

Résumé

In July 2022, New York State (NYS) reported a case of paralytic polio in an unvaccinated young adult, and subsequent wastewater surveillance confirmed sustained local transmission of type 2 vaccine-derived poliovirus (VDPV2) in NYS with genetic linkage to the paralyzed patient. We adapted an established poliovirus transmission and oral poliovirus vaccine (OPV) evolution model to characterize dynamics of poliovirus transmission in NYS, including consideration of the immunization activities performed as part of the declared state of emergency. Despite sustained transmission of imported VDPV2 in NYS involving potentially thousands of individuals (depending on seasonality, population structure and mixing assumptions) in 2022, the expected number of additional paralytic cases in years 2023 and beyond is small (less than 0.5). However, continued transmission and/or reintroduction of poliovirus into NYS and other populations remains a possible risk in communities that do not achieve and maintain high immunization coverage. In countries such as the US that use only inactivated poliovirus vaccine, even with high average immunization coverage, imported polioviruses may circulate and pose a small but non-zero risk of causing paralysis in non-immune individuals.

Sections du résumé

BACKGROUND BACKGROUND
In July 2022, New York State (NYS) reported a case of paralytic polio in an unvaccinated young adult, and subsequent wastewater surveillance confirmed sustained local transmission of type 2 vaccine-derived poliovirus (VDPV2) in NYS with genetic linkage to the paralyzed patient.
METHODS METHODS
We adapted an established poliovirus transmission and oral poliovirus vaccine (OPV) evolution model to characterize dynamics of poliovirus transmission in NYS, including consideration of the immunization activities performed as part of the declared state of emergency.
RESULTS RESULTS
Despite sustained transmission of imported VDPV2 in NYS involving potentially thousands of individuals (depending on seasonality, population structure and mixing assumptions) in 2022, the expected number of additional paralytic cases in years 2023 and beyond is small (less than 0.5). However, continued transmission and/or reintroduction of poliovirus into NYS and other populations remains a possible risk in communities that do not achieve and maintain high immunization coverage.
CONCLUSION CONCLUSIONS
In countries such as the US that use only inactivated poliovirus vaccine, even with high average immunization coverage, imported polioviruses may circulate and pose a small but non-zero risk of causing paralysis in non-immune individuals.

Identifiants

pubmed: 37596838
pii: 7246204
doi: 10.1093/infdis/jiad355
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.

Auteurs

Kimberly M Thompson (KM)

Kid Risk, Inc., Orlando, FL, USA.

Dominika A Kalkowska (DA)

Kid Risk, Inc., Orlando, FL, USA.

Janell A Routh (JA)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

I Ravi Brenner (IR)

Office of Public Health, New York State Department of Health, Albany, NY, USA.

Eli S Rosenberg (ES)

Office of Public Health, New York State Department of Health, Albany, NY, USA.
Department of Epidemiology and Biostatistics, State University of New York at Albany, Albany, NY, USA.

Jane R Zucker (JR)

New York City Department of Health and Mental Hygiene, New York, NY, USA.
Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Marisa Langdon-Embry (M)

New York City Department of Health and Mental Hygiene, New York, NY, USA.

David E Sugerman (DE)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Cara C Burns (CC)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Kamran Badizadegan (K)

Kid Risk, Inc., Orlando, FL, USA.

Classifications MeSH